Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Dermata Therapeutics, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/05/2023 |
4
| Bedoya-Toro Munera Maria E (SVP, Regulatory Affairs) has filed a Form 4 on Dermata Therapeutics, Inc.|
Txns:
| Granted 50,000 options to buy
@ $0.31, valued at
$15.5k
|
|
| 01/05/2023 |
4
| Van Hoose Kyri K. (SVP, CFO) has filed a Form 4 on Dermata Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $0.31, valued at
$31k
|
|
| 01/05/2023 |
4
| Nardo Christopher J. (Senior VP, CDO) has filed a Form 4 on Dermata Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $0.31, valued at
$31k
|
|
| 10/07/2022 |
4
| Sandler Andrew Seth (Director) has filed a Form 4 on Dermata Therapeutics, Inc.|
Txns:
| Granted 10,120 shares
@ $0 |
|
| 10/07/2022 |
4
| Bradrick Brittany (Director) has filed a Form 4 on Dermata Therapeutics, Inc.|
Txns:
| Granted 9,810 shares
@ $0 |
|
| 10/07/2022 |
4
| HALE DAVID F (Director) has filed a Form 4 on Dermata Therapeutics, Inc.|
Txns:
| Granted 30,155 shares
@ $0 |
|
| 10/07/2022 |
4
| FISHER MARY (Director) has filed a Form 4 on Dermata Therapeutics, Inc.|
Txns:
| Granted 9,810 shares
@ $0 |
|
| 10/07/2022 |
4
| Scott Kathleen D. (Director) has filed a Form 4 on Dermata Therapeutics, Inc.|
Txns:
| Granted 11,359 shares
@ $0 |
|
| 10/07/2022 |
4
| WIERENGA WENDELL (Director) has filed a Form 4 on Dermata Therapeutics, Inc.|
Txns:
| Granted 20,654 shares
@ $0 |
|
| 07/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/08/2022 |
4
| Bradrick Brittany (Director) has filed a Form 4 on Dermata Therapeutics, Inc.|
Txns:
| Granted 8,602 shares
@ $0 |
|
| 07/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/08/2022 |
4
| WIERENGA WENDELL (Director) has filed a Form 4 on Dermata Therapeutics, Inc.|
Txns:
| Granted 18,110 shares
@ $0 |
|
| 07/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/07/2022 |
4
| Nardo Christopher J. (Senior VP, CDO) has filed a Form 4 on Dermata Therapeutics, Inc.|
Txns:
| Granted 30,000 options to buy
@ $0.513, valued at
$15.4k
|
|
| 04/08/2022 |
4
| WIERENGA WENDELL (Director) has filed a Form 4 on Dermata Therapeutics, Inc.|
Txns:
| Granted 10,593 shares
@ $0 |
|
| 04/08/2022 |
4
| FISHER MARY (Director) has filed a Form 4 on Dermata Therapeutics, Inc.|
Txns:
| Granted 5,031 shares
@ $0 |
|
| 04/08/2022 |
4
| Scott Kathleen D. (Director) has filed a Form 4 on Dermata Therapeutics, Inc.|
Txns:
| Granted 5,826 shares
@ $0 |
|
| 04/08/2022 |
4
| Sandler Andrew Seth (Director) has filed a Form 4 on Dermata Therapeutics, Inc.|
Txns:
| Granted 5,190 shares
@ $0 |
|
| 04/08/2022 |
4
| Bradrick Brittany (Director) has filed a Form 4 on Dermata Therapeutics, Inc.|
Txns:
| Granted 5,031 shares
@ $0 |
|
| 04/08/2022 |
4
| HALE DAVID F (Director) has filed a Form 4 on Dermata Therapeutics, Inc.|
Txns:
| Granted 15,466 shares
@ $0 |
|
| 01/14/2022 |
4
| Bradrick Brittany (Director) has filed a Form 4 on Dermata Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $1.5, valued at
$15k
|
|
| 01/05/2022 |
4
| Sandler Andrew Seth (Director) has filed a Form 4 on Dermata Therapeutics, Inc.|
Txns:
| Granted 5,000 options to buy
@ $1.88, valued at
$9.4k
|
|
| 01/05/2022 |
4
| Nardo Christopher J. (Senior VP, Development) has filed a Form 4 on Dermata Therapeutics, Inc.|
Txns:
| Granted 30,000 options to buy
@ $1.88, valued at
$56.4k
|
|
| 01/05/2022 |
4
| Van Hoose Kyri K. (SVP, CFO) has filed a Form 4 on Dermata Therapeutics, Inc.|
Txns:
| Granted 30,000 options to buy
@ $1.88, valued at
$56.4k
|
|
| 01/05/2022 |
4
| HALE DAVID F (Director) has filed a Form 4 on Dermata Therapeutics, Inc.|
Txns:
| Granted 5,000 options to buy
@ $1.88, valued at
$9.4k
|
|
| 01/05/2022 |
4
| WIERENGA WENDELL (Director) has filed a Form 4 on Dermata Therapeutics, Inc.|
Txns:
| Granted 5,000 options to buy
@ $1.88, valued at
$9.4k
|
|
| 01/05/2022 |
4
| Scott Kathleen D. (Director) has filed a Form 4 on Dermata Therapeutics, Inc.|
Txns:
| Granted 5,000 options to buy
@ $1.88, valued at
$9.4k
|
|
| 01/05/2022 |
4
| Mento Steven J (Director) has filed a Form 4 on Dermata Therapeutics, Inc.|
Txns:
| Granted 5,000 options to buy
@ $1.88, valued at
$9.4k
|
|
| 01/05/2022 |
4
| FISHER MARY (Director) has filed a Form 4 on Dermata Therapeutics, Inc.|
Txns:
| Granted 5,000 options to buy
@ $1.88, valued at
$9.4k
|
|
| 01/05/2022 |
4
| Bedoya-Toro Munera Maria E (Senior Vice President) has filed a Form 4 on Dermata Therapeutics, Inc.|
Txns:
| Granted 15,000 options to buy
@ $1.88, valued at
$28.2k
|
|
| 01/05/2022 |
4
| PROEHL GERALD T (President, CEO and Chairman) has filed a Form 4 on Dermata Therapeutics, Inc.|
Txns:
| Granted 197,610 options to buy
@ $1.88, valued at
$371.5k
Granted 4,517 options to buy
@ $2.068, valued at
$9.3k
Granted 42,141 options to buy
@ $2.068, valued at
$87.1k
Granted 57,859 options to buy
@ $1.88, valued at
$108.8k
|
|
| 11/26/2021 |
4
| PROEHL GERALD T (President, CEO and Chairman) has filed a Form 4 on Dermata Therapeutics, Inc.|
Txns:
| Bought 20,000 shares
@ $2.4, valued at
$48k
|
|
|
|
|